← Leaderboards
Paul Zhou
Southwest Foundation For Biomedical Res
$1,459,923
Attributed
$1,459,923
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,459,923 · 4
By mechanism
R01$1,136,160 · 1
R21$247,635 · 1
P51$76,128 · 2
Top collaborators
No co-investigators on record.
Most similar at Southwest Foundation For Biomedical Res
Same institution · by research overlap
- Jason T Kimata$11,879,127
- Kathleen M Brasky$521,454
- Robert E Lanford$16,891,565
- Jeffrey A Rogers$19,218,865
- Karen S Rice$3,142,097
Others in their field
Top investigators on “Antiaids Agent”
- Constance Ann Benson · University Of California, San Diego$85,157,000
- Willard Cates · Family Health International$66,963,584
- Stephen A Spector · University Of California, San Diego$62,271,387
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Robert Turner Schooley · University Of Colorado Denver$46,857,922
- Douglas D Richman · University Of California San Diego$18,822,170
Research focus
Antiaids AgentHuman Immunodeficiency Virus 1Helper T LymphocyteSite Directed MutagenesisLaboratory MouseGenetically Modified AnimalsMicroorganism ImmunologyCellular ImmunityCytokineHuman TissueModel Design /DevelopmentNorthern BlottingsPolymerase Chain ReactionPrimatesReceptorReceptor BindingWestern BlottingsAnimal ColonyXenotransplantationAntiviral AgentsBiological Signal TransductionChimeric ProteinsCytotoxic T LymphocyteDisease /Disorder Model
Grant awards (7)
DEVELOPMENT OF A XENOGRAFT MODEL TO TEST ANTI-SHIV ACTIVITY$13,652
P51 · FY2004 · RR
FURTHER STUDIES ON ANTI HIV 1 ACTIVITY OF INTERLEUKIN 16$287,000
R01 · FY2003 · AI
Inhibition of HIV by Novel Chimeric Receptors$247,635
R21 · FY2003 · AI
DEVELOPMENT OF A XENOGRAFT MODEL TO TEST ANTI-SHIV ACTIVITY$62,476
P51 · FY2003 · RR
FURTHER STUDIES ON ANTI HIV 1 ACTIVITY OF INTERLEUKIN 16$287,000
R01 · FY2002 · AI
FURTHER STUDIES ON ANTI HIV 1 ACTIVITY OF INTERLEUKIN 16$287,000
R01 · FY2001 · AI
FURTHER STUDIES ON ANTI HIV 1 ACTIVITY OF INTERLEUKIN 16$275,160
R01 · FY2000 · AI